Mr. Thomas Baruch serves as Advisor at Tachyus. He served as Partner at Formation 8. He founded CMEA Capital in 1989. At Exxon, he managed investments and created several early-stage technology companies applying materials science and semiconductor-industry technologies such as Supertex (SUPX). He formed CMEA Capital with New Enterprise Associates (NEA) in 1989 after previously having founded and served as CEO of Microwave Technology, a supplier of gallium arsenide integrated circuits and value-added sub-systems. He was one of the original investors in Aclara Biosciences (which merged with Monogram Biosciences - NASDAQ: MRGM), Flextronics (FLEX), Netro (NTRO), Silicon Spice (acquired by BRCM) and Symyx Technologies (SMMX). He currently heads up the firm's energy and materials investments to include fuel cells, solar power generation and management, biofuels and rechargeable batteries, among others. He continues to engage in his passion for early-stage investments by serving as Chairman of the Board of materials and energy companies including: Codexis, Inc., Cnano Technologies, Intermolecular and Wildcat Discovery Technologies. He also currently serves on the boards of Biolight, Entropic Communications (ENTR), Exela, Luminus Devices and Solyndra. Mr. Baruch holds an engineering degree from Rensselaer Polytechnic Institute and a Juris Doctor degree from Capital University. He is a registered patent attorney and is also a member of the Board of Trustees of Rensselaer Polytechnic Institute, the Board of Trustees of the Berkeley Institute for Synthetic Biology (BISB) and the Board of Trustees of That Man May See Foundation. He also serves as chairman and board member at Physiometrix. He also served as an Executive Chairman of the Board at Calysta Energy. He also serves as an Advisor at 8VC. He serves as a Board Member at LaunchPad Central.